- Respiratory GenBody COVID-19 Ag
The GenBody COVID-19 Ag is a lateral flow immunoassay
intended for the qualitative detection of nucleocapsid antigen
from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of being infected with SARS-CoV-2 by their healthcare provider within the first 6 days of onset of symptoms.
Emergency Use Authorization (EUA) approved.
Catalog Number: COVAG025-NU
Support & Documents
Nasal Swab sample type can be used with GenBody COVID-19 Ag.
It is not recommended to use transport media with nasal swabs.
Yes, the GenBody COVID-19 Ag kit includes 1 positive and 1 negative control swab.
It is suggested to use CPT 87811, and for the CLIA waiver, add a QW designator.